References
Melmed S, Polonsky KS, Reed Larsen P, Kronenberg H (2011) Chapter 28 Hormones and disorders of mineral metabolism in Williams textbook of endocrynology. Elsevier, Philadelphia
Oberg J, Jorde R, Almas B, Emaus N, Grimnes G (2014) Vitamin D deficiency and lifestyle risk factors in a Norwegian adolescent population. Scand J Public Health 42(7):593–602
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281
Scharla SH (1998) Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 8(Suppl 2):S7–12
Gordon CM, Feldman HA, Sinclair L et al (2008) Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162(6):505–512
Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158(6):531–537
Huh SY, Gordon CM (2008) Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord 9(2):161–170
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477–501
Ahmad R, Hammond JM (2004) Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin N Am 37(4):701–713 vii-viii
Gasser RW (2013) Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr 163(17–18):397–402
Lila AR, Sarathi V, Jagtap V, Bandgar T, Menon PS, Shah NS (2012) Renal manifestations of primary hyperparathyroidism. Indian J Endocrinol Metab 16(2):258–262
Bilezikian JP (2003) Bone strength in primary hyperparathyroidism. Osteoporos Int 14(Suppl 5):S113–S115 discussion S5–7
Press DM, Siperstein AE, Berber E et al (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1237 discussion 7-8
Alshehri MY (1999) A hospital-based survey of primary hyperparathyroidism in the Asir region: low prevalence or underdiagnosis? Ann Saudi Med 19(4):322–324
Yu N, Leese GP, Smith D, Donnan PT (2011) The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 104(6):513–521
Palmer M, Jakobsson S, Akerstrom G, Ljunghall S (1988) Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Investig 18(1):39–46
Ruda JM, Hollenbeak CS, Stack BC Jr (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132(3):359–372
Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6(4):913–921
Giusti A, Barone A, Razzano M et al (2006) High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Investig 29(9):809–813
Owda A, Elhwairis H, Narra S, Towery H, Osama S (2003) Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race. Ren Fail 25(4):595–602
Murphy E, Williams GR (2009) Hypocalcaemia. Medicine 37(9):465–468
Witteveen JE, van Thiel S, Romijn JA, Hamdy NA (2013) Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168(3):R45–R53
Gurevich Y, Poretsky L (2008) Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate. Otolaryngol Head Neck Surg 138(3):403–404
Kumar A, Ralston SH (1996) Bisphosphonates prevent the hungry bone syndrome. Nephron 74(4):729
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Gorter, E.A., Kluck, A.J.C.G.D., Krijnen, P. et al. Pathological fractures in a patient with severe osteomalacia and hyperparathyroidism: a multidisciplinary challenge. Arch Osteoporos 12, 74 (2017). https://doi.org/10.1007/s11657-017-0367-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-017-0367-7